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Background. Despite major advances in perinatal medicine, intrapartum asphyxia remains a leading and potentially preventable
cause of perinatal mortality and long-term morbidity. The umbilical cord pH is considered an essential criteria for the diagnosis
of acute intrapartum hypoxic events. The purpose of this study was to evaluate whether obstetric risk factors are associated with
fetal acidaemia at delivery. Methodology. In a case-control study, 294 women with term singleton pregnancies complicated by an
umbilical artery cord pH < 7.20 at birth were individually matched by controls with umbilical artery cord pH > 7.20. Groups were
compared for differences in maternal, obstetric, and fetal characteristics using logistic regression models presented as odds ratio
(OR) with 95% confidence intervals (CI). Results.The study showed pregestational diabetes (PGDM) [OR: 5.31, 95% CI: 1.15- 24.58,
P = 0.018], urinary tract infection (UTI) [OR: 3.21, 95% CI: 1.61- 6.43, P < 0.001], and low Apgar scores to be significantly associated
with acidaemia, whereas low maternal BMI [OR: 0.19, 95% CI: 0.04-0.87, P = 0.032], pyrexia in labour [OR 0.23; 95% CI 0.12-
0.53; P < 0.001], electronic fetal monitoring (EFM) [OR 0.65; 95% CI 0.43-0.99; P = 0.042), and emergency caesarean section [OR
0.42; 95% CI 0.26-0.66; P < 0.001] were found to be protective of acidaemia. Conclusion. Certain obstetric risk factors before and
during labour can identify newborns at risk of developing acidaemia. Further research is needed to gain quantitative insight into
the predictive capacity of these risks that can inform obstetric clinical management for improved outcomes.
1. Introduction
Intrapartum fetal hypoxia, resulting in permanent neurolog-
ical impairment, remains a significant source of concern for
parents and healthcare professionals [1]. Today, electronic
fetal monitoring (EFM) is the most common method used to
assess for fetal well-being during labour without substantial
evidence to suggest a benefit [2]. Despite its widespread
use over the last four decades, the incidence of intrapartum
fetal hypoxia culminating in long-term neurological sequelae
(cerebral palsy) or perinatal death has remained largely
unchanged [3, 4]. Numerous clinical studies have investigated
the relationship between neonatal complications and umbil-
ical artery pH [5–7]. However, few studies have analysed
the risk factors for fetal acidosis [6, 8]. Our purpose was to
employ a case-control design to identify possible risk factors
during pregnancy and delivery for fetal acidaemia at birth
that could help obstetricians recognise patients who have
a higher risk of developing fetal and subsequent neonatal
acidaemia. The recognition of an epidemiological profile
could help identify women requiring intensive surveillance
during labour, thereby enabling expedited delivery before
permanent neurological damage ensues [8].
2. Materials and Methods
This was a retrospective case-control study from June 1,
2016, to January 31, 2017. The study was performed at
the Jessop Wing of the Sheffield Teaching Hospitals Trust,
a tertiary-referral University hospital where approximately
8000 deliveries take place annually. Data was collected from
a cohort of consecutive delivering women with a singleton
nonanomalous cephalic fetus at more than 37 gestational
weeks. Acidaemia was defined as pH < 7.20 on the arterial
blood samples obtained from the umbilical cord at birth.
This level was used as pH of <7.20 on fetal blood sampling
Hindawi
Journal of Pregnancy
Volume 2018, Article ID 2195965, 8 pages
https://doi.org/10.1155/2018/2195965
2 Journal of Pregnancy
is defined as abnormal in current intrapartum guidelines of
the UK and is used to prompt immediate delivery [9]
Cord blood gas samples were analysed using an ABL
800 Series blood gas analysers situated on the labour
ward and maternity theatres of the hospital. Cord blood
gas results obtained utilising the blood gas analyser were
downloaded into a database for this study. For the case
group, newborns with umbilical arterial cord blood pH <
7.20 were included. The control group included newborns
with a normal umbilical artery cord blood pH > 7.20 born
consecutively following each newborn included in the case
group. For all cases and controls, data from the standardized
antenatal, intrapartum, and birth outcome records were
collected from the hospital electronic maternity database
and medical notes. Antenatal data were split into several
factors: maternal demographic, chronic maternal disease,
previous obstetric history, and current pregnancy problems.
Maternal demographic included age, BMI, ethnicity, and
parity. Maternal age was defined by criteria suggested by
the RCOG [10]: normal 20-34 years, teenage <20 years,
advanced maternal age I >35 years, and advanced maternal
age II >40 years. As recommended by NICE [11], BMI <18.5
was defined as underweight (18.5-24.9), healthy (25-29.9),
Class I obesity (30-34.9), Class II obesity (35-39.9), and
Class III obesity (40 or more). Parity was grouped according
to Bai et al. [12]: nulliparity as 0, low multiparity as 1-
3, and grand multiparity as 4-8. Chronic maternal disease
included pregestational diabetes mellitus (PGDM), preexist-
ing cardiac, respiratory, autoimmune, haematological, and
thyroid disorder whereas past obstetric history included
miscarriage, preterm delivery, stillbirth, and caesarean sec-
tion. Current pregnancy problems included hypertensive
disorder, obstetric cholestasis, gestational diabetes mellitus
(GDM), intrauterine growth restriction (IUGR), reduced
fetal movement, and proven urinary tract infection (UTI).
Intrapartum risk factors included induced labour, oxytocin-
augmented labour,meconium-stained amniotic fluid, pyrexia
in labour, epidural analgesia, and operative deliveries. Sev-
eral neonatal outcomes were compared between acidaemic
and nonacidaemic neonates. Neonatal outcomes that were
examined included birth weight, Apgar score at 1 and 5 min,
and neonatal intensive care unit (NICU) admission.The rela-
tionship between antenatal and intrapartum risk factors for
fetal acidaemia was analysed using logistic regression model
presented as odds ratio (OR) with 95% confidence intervals
(CI).This study was conducted as a service evaluation project
so formal ethical approval was not required.
2.1. Statistical Analysis. SPSS version 24 statistical package
was used for all analyses. Baseline characteristics were deter-
mined using descriptive statistics and presented as mean ± a
standard deviation for continuous variables and as numbers
and percentages for categorical and dichotomous variables. A
comparison between cases and controls was performed with
chi-square or Fisher exact tests, when appropriate for cate-
gorical variables. Fisher’s exact test was used when assump-
tions of the chi-square test were violated. A probability
value of <0.05 was considered statistically significant. Binary
logistic regression was used to investigate the independent
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Figure 1: Distribution of maternal BMI between the two groups.
contribution of obstetric factors to the occurrence of fetal
acidaemia. Odds ratios and their 95% CIs were calculated
from the regression coefficient to estimate the strength of
association with each parameter.
3. Results
Between June 1, 2016, and January 31, 2017, there were 3184
singleton term live births at the JessopWing.Of 3184, 2115 sets
of data were recorded by the blood gas analysing machine.
After excluding insufficient, poor quality, and incorrectly
labelled umbilical cord blood samples, there were 1112 umbil-
ical cord results. Of 1112 umbilical cord results, 328 cord blood
values had a pH less than 7.20; 294 of these were arterial cord
gases. Thus 294 cord blood values made up the acidaemia
group of this study.
Maternal demographics, obstetric characteristics, deliv-
ery and neonatal outcomes according to the study groups
are shown in Tables 1, 2, and 3, respectively. There were
no differences between the case and controls in terms of
age, parity, ethnicity, rates of gestational diabetes, obstet-
ric cholestasis, thyroid, cardiac, respiratory, rheumatology,
haematology, and hypertensive disorders but a difference in
maternal BMI, UTI, and PGDM was observed between the
two groups. With regard to maternal BMI, although we had
only 13 women in the study with a BMI of <18.5, underweight
women seemed to be protective against neonatal acidaemia
(OR 0.19; 95% CI 0.04-0.87; P=0.032). On the other hand, a
stepwise trend towards acidaemia with increasing BMI was
observed; odds ratios increased from 1.10 in the group with
a BMI between 25 and 30 to 1.30 between 30 and 35 to 2.07
with BMI > 40 (see Figure 1).
Although number of women with chronic health condi-
tions such as thyroid, rheumatology, respiratory, and haema-
tology problems were slightly higher in the acidaemia group,
this difference was not statistically significant. However, a
significantly increased proportion of women with PGDM
were observed in the acidaemia group (5.3%) compared to the
controls (1.1%); P = 0.018. From logistic regression analysis,
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we estimated that infants of women with PGDM were five
times more likely to be acidotic (OR 5.31; 95% CI 1.15-24.58)
compared to the controls.
Interestingly, women with UTI during pregnancy showed
a significantly increased occurrence of neonatal acidaemia
compared to the control group (18.5% versus 6.6%; P <
0.001). However the presence of other obstetric risk factors in
the previous or current pregnancy was broadly comparable
between the two groups.
Antenatal risk factors were included in a logistic regres-
sion model to find independence of results. The results of
multivariable analysis demonstrated antenatal UTI to be a
significant predictor for neonatal acidaemia (OR 3.62; 95%
CI 1.57-8.34; P = 0.003).
Surprisingly, most of the intrapartum risk factors showed
a significant trend towards nonacidaemia. Among all intra-
partum variables, pyrexia in labour had the largest amount
of missing data. However, this variable was significantly
associated with nonacidaemia (OR 0.23; 95% CI 0.12-0.53;
P < 0.001). In addition, the number of women who had
continuous CTG monitoring during labour was significantly
higher in the control group compared to the cases (83.6%
versus 76.8%; P = 0.042). Women in the acidaemia group
had significantly shorter labours than women in the nonaci-
daemia group (705 minutes compared to 811 minutes; P
= 0.011). The majority of deliveries in the nonacidaemia
group were emergency caesarean sections (55%). However,
in the acidaemia group, instrumental delivery made up the
largest group (45.0%). Abinary logistic regressionwas carried
out to compare instrumental, emergency caesarean, and
elective caesarean section delivery with unassisted delivery.
The logistic regression showed that emergency caesarean
section compared to unassisted deliveries was significantly
associated with nonacidaemia (OR 0.42; 95% CI 0.26-0.66;
P < 0.001).
With regard to neonatal outcomes low Apgar scores at
1 and 5 minutes were significantly associated with neonatal
acidaemia (P < 0.001 and P = 0.025). However, there were no
significant differences in the neonatal birthweight and NICU
admissions between the two groups.
4. Discussion
The data from this study demonstrates that several obstetric
risk factors such as urinary tract infection during pregnancy,
pregestational diabetes mellitus, and instrumental delivery
increase a higher risk of acidaemia at birth.
Fetal oxygenation and umbilical cord pH usually decline
during the course of normal labour [13]. The exact pH value
which defines significant acidosis remains unclear. Most
studies quote arterial cord pH< 7.20 as a cut-off for significant
acidosis [13, 14], whereas Goldaber et al. [15] suggest that
most fetuses would tolerate intrapartum acidaemia with a
pH as low as 7.00. From an important systematic review and
meta-analysis [16], it is known that low umbilical artery cord
pH is strongly associated with clinically important neonatal
and long-term adverse outcomes. Hence prevention of low
cord pH at birth by recognising woman’s individual risk
of developing such adverse outcome, preferably at an early
stage, optimises the intrapartum monitoring, decision and
management process.
During pregnancy, obesity has been related to several
obstetric and fetal complications, and the effect is dose-
dependent [17]. On the other hand, there is only a small
amount of data available about the relationship between being
underweight during pregnancy and perinatal complications
[18]; in fact the risk of several pregnancy, intrapartum,
postnatal, and neonatal complications are less common in
underweight women [19]. Results from our study support
this notion and demonstrate that low maternal BMI was
protective of acidaemia at birth.
Pregnancies affected by diabetes mellitus are at increased
risk of perinatal morbidity and mortality as a consequence
of poor maternal blood sugar control [20]. Fetuses of PGDM
appear to be exposed to chronic intrauterine hypoxia and
have been found to be acidaemic at cordocentesis even in
the presence of normal biophysical score [21]. A recent
study found significant association between fetal acidaemia
at delivery and decreased neonatal heart rate variability in
infants of PGDM [22]. Landon et al. [23] demonstrated
a linear relationship between maternal glucose levels and
adverse pregnancy outcome. In addition, a large population
based study demonstrated significantly increased maternal
and perinatal morbidity in women with PGDM compared to
GDM [24]. Thus, it would be logical that PGDM, which is
more likely to have elevated glucose levels in early pregnancy,
would have increased adverse perinatal outcome compared
to GDM. Our results confirm this expectation.
The incidence of UTI in pregnancy can be as high as eight
percent and maternal and neonatal complications associated
withUTI can be devastating [25].Our study confirm thatUTI
at any stage in pregnancy increases the odds of acidaemia at
birth threefold compared to women who never had a UTI.
The significant association between UTI and acidaemia at
birth persisted when multivariable analyses were performed
to control for potential confounding factors such as age and
parity. This finding is unique and there is no literature to
confirm or refute this observation.
When instrumental and caesarean deliveries were com-
pared, whether the indication for operative delivery was fetal
compromise or failure to progress in labour, arterial cord pH
was worse in the instrumental group. These results are in
agreement with existing evidence in literature [1, 14] and are
explained by longer period of in utero resuscitation following
a decision to deliver by caesarean section in contrast to
shorter decision to delivery interval for babies delivered by
instrumental delivery. This further explains why we observed
shortened labour duration in the acidaemia group compared
to the nonacidaemia group.
The presence of maternal fever in labour (chorioam-
nionitis) is a strong risk factor for adverse neonatal outcome
including cerebral palsy and neonatal death [26]. However,
studies evaluating its association with umbilical cord gases
at birth have found no significant effect on cord pH [27].
Strikingly, our study found pyrexia in labour to have pro-
tective effect on acidaemia. It is plausible that women with
pyrexia in labour were closely monitored and a threshold
of intervention (delivery by caesarean section) was probably
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lower in this group resulting in better neonatal outcome.
Furthermore, this variable had a lot of missing data, meaning
that the accuracy of this association cannot be conclusively
established.
In our study, EFM was performed in 76.8% of the cases
and in 88.6% of the control group. The impact of EFM on
neonatal outcome continues to be controversial [28]. A recent
Cochrane review have failed to show any improvement in
perinatal outcome with their use [4]. Intrapartum CTG has
low specificity with many nonacidaemic fetuses having CTG
changes [29].
With regard to delivery variables, we observed a clear
reduction of Apgar scores with lower values of umbilical
artery cord pH. This finding is consistent with previous
studies [5, 14].
We acknowledge several limitations of this study. First,
cord gas sampling was poor, incomplete, and incorrectly
labelled in 47.4% of the cases. This data was excluded from
the analysis, which raises a possibility of missing some subtle
but potentially clinically interesting information that may
have given us a better insight and helped obstetricians in
recognising patients at higher risk of developing fetal and
subsequent neonatal acidaemia.
Second, because of the retrospective nature of this study,
we were unable to control for all possible confounding vari-
ables and were limited to information previously obtained.
Third, we analysed only arterial pH as this is the most
commonly used measure instead of taking into consideration
other criteria of intrapartum asphyxia [30]. In addition, we
defined acidaemia as an umbilical artery pH < 7.20 which
is slightly higher than the definition used by the majority
of publications on this subject. Nonetheless, there is no
consensus on a single umbilical cord artery pH that clearly
distinguishes acidotic babies from those that are nonacidotic
[31]. Furthermore, if we had chosen pH < 7.0 instead of pH <
7.20 as an outcome measure, although we may have observed
significant risk factors for acidaemia, the reliability and sig-
nificance of these results would have been questioned due to
limited sample size as there were only 17 cases with an umbil-
ical artery pH < 7.0 between June 1, 2016, January 31, 2017.
Fourth, the study was not population based, with limited
sample size and missing data for most of the variables
ranged from 0 to 82.1%; therefore the possibility that bias
affected the results of this study must be considered. Fifth,
we were unable to assess long-term neonatal outcomes that
include developmental delay, neurological morbidity, and
cerebral palsy. Finally, cord gas data were not available for
many women, because, in our institution, it is not common
practice to obtain cord blood gas, as a means of additional
assessment in deliveries with an Apgar score of ≥7. Although
most neonates who are born with acidaemia will not require
additional intervention or develop subsequent morbidity,
conclusion from a systematic review and meta-analysis [16]
indicates that “initial surveillance of neonates born with a
low arterial cord pH, regardless of their clinical condition,
is warranted as the odds of complications have been shown
to be higher in this group”. Based on this conclusion, we find
merit in universal umbilical cord blood sampling as amethod
of identifying neonates who are at risk.
In conclusion, our study has shown that, in women with
singleton term pregnancy, factors both before and during
labour influence the possibility of developing acidosis of the
newborn at birth. While association does not necessarily
imply causation, there are good physiological grounds for
expecting some causal relationship to be operating. Further
studies are needed to validate our results, establish that
causality of this association and to assess long-term outcome
of these babies.
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